Baylor Genetics has been honored with a Bronze Stevie® Award for Technical Innovation of the Year, Biotechnology, at the 2026 Stevie® Awards for Technology Excellence, recognizing our Innovative Multimodal Solutions for Rare Disease Diagnostics.
This award highlights our commitment to advancing rare disease diagnosis through cutting-edge genomic technologies, including our Whole Genome Sequencing, integrated multimodal approaches, and data-driven insights that help clinicians uncover answers for patients and families seeking a diagnosis.
Every innovation at Baylor Genetics is guided by our mission to shorten the diagnostic odyssey and improve patient care. This recognition reflects the dedication of our teams and the impact of our genome-first approach in helping healthcare providers deliver more informed care.
As we continue to expand the possibilities of genomic medicine, we remain focused on accelerating diagnosis, supporting clinical decision-making, and improving outcomes for patients with rare and genetic conditions.
Learn more about the Stevie Awards for Technology Excellence here.
